Susquehanna International Group, LLP Johnson & Johnson Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Johnson & Johnson stock. As of the latest transaction made, Susquehanna International Group, LLP holds 457,875 shares of JNJ stock, worth $66.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

457,875

Previous 735,310 37.73%

Holding current value

$66.8 Million

Previous $107 Million 30.96%

% of portfolio

0.01%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $40.4 Million - $46.4 Million	-277,435 Reduced 37.73%	457,875 $74.2 Million
Q2 2024 Aug 15, 2024	SELL	$144.38 - $157.78 $9.17 Million - $10 Million	-63,517 Reduced 7.95%	735,310 $107 Million
Q1 2024 May 07, 2024	SELL	$155.22 - $162.74 $49.7 Million - $52.1 Million	-319,871 Reduced 28.59%	798,827 $126 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $63.2 Million - $69 Million	-434,341 Reduced 27.97%	1,118,698 $175 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $40.9 Million - $45.9 Million	262,909 Added 20.38%	1,553,039 $242 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $96.9 Million - $104 Million	-627,550 Reduced 32.72%	1,290,130 $214 Million
Q1 2023 May 16, 2023	BUY	$151.05 - $180.26 $132 Million - $157 Million	872,593 Added 83.49%	1,917,680 $297 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $139 Million - $156 Million	867,631 Added 488.93%	1,045,087 $185 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $55.3 Million - $61.5 Million	-342,473 Reduced 65.87%	177,456 $29 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $38.8 Million - $42.9 Million	-230,798 Reduced 30.74%	519,929 $92.3 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $11.9 Million - $13.5 Million	75,353 Added 11.16%	750,727 $133 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $110 Million - $123 Million	-708,230 Reduced 51.19%	675,374 $116 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $10.6 Million - $11.8 Million	-65,758 Reduced 4.54%	1,383,604 $223 Million
Q2 2021 Aug 11, 2021	BUY	$159.48 - $171.07 $130 Million - $139 Million	812,723 Added 127.66%	1,449,362 $239 Million
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $30.3 Million - $33.8 Million	-198,100 Reduced 23.73%	636,639 $105 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $14.4 Million - $16.5 Million	104,758 Added 14.35%	834,739 $131 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $65.9 Million - $72.2 Million	-469,173 Reduced 39.13%	729,981 $109 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $137 Million - $166 Million	1,067,367 Added 809.92%	1,199,154 $169 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $62.3 Million - $86.3 Million	-560,455 Reduced 80.96%	131,787 $17.3 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $3 Million - $3.44 Million	23,509 Added 3.52%	692,242 $101 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $71.1 Million - $79.6 Million	559,958 Added 514.79%	668,733 $86.5 Million
Q2 2019 Aug 16, 2019	BUY	$131.15 - $144.24 $4.28 Million - $4.71 Million	32,668 Added 42.92%	108,775 $15.2 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $43 Million - $47.2 Million	-327,504 Reduced 81.14%	76,107 $10.6 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $43.3 Million - $47.8 Million	362,696 Added 886.46%	403,611 $49 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $28.9 Million - $34.2 Million	-231,034 Reduced 84.95%	40,915 $5.24 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $20.6 Million - $22.6 Million	157,280 Added 137.16%	271,949 $38 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $14.8 Million - $15.5 Million	114,669	114,669 $14.9 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Johnson & Johnson Transaction History